New Data Affirms Strength of UCB Immuno-Dermatology Portfolio
Go back to New Data Affirms Strength of UCB Immuno-Dermatology Portfolio| (NYSE: UCB) | Delayed: 35.50 -0.03 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.53 | 52 Week High | $ | |||
| Open | $35.83 | 52 Week Low | $ | |||
| Day High | $35.91 | P/E | N/A | |||
| Day Low | $35.28 | EPS | $ | |||
| Volume | 190,299 | |||||
| UCB Unsponsored ADR (AMEX: UCBJY) | Delayed: 129.19 +3.08 (2.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $126.11 | 52 Week High | $46.25 | |||
| Open | $127.28 | 52 Week Low | $32.74 | |||
| Day High | $129.37 | P/E | N/A | |||
| Day Low | $127.28 | EPS | $0.00 | |||
| Volume | 20,210 | |||||
